151 related articles for article (PubMed ID: 24791989)
21. A new versatile peptide-based size exclusion chromatography platform for global profiling and quantitation of candidate biomarkers in hepatocellular carcinoma specimens.
Lee HJ; Na K; Kwon MS; Park T; Kim KS; Kim H; Paik YK
Proteomics; 2011 May; 11(10):1976-84. PubMed ID: 21500349
[TBL] [Abstract][Full Text] [Related]
22. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry.
Hu S; Yu T; Xie Y; Yang Y; Li Y; Zhou X; Tsung S; Loo RR; Loo JR; Wong DT
Cancer Genomics Proteomics; 2007; 4(2):55-64. PubMed ID: 17804867
[TBL] [Abstract][Full Text] [Related]
23. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
[TBL] [Abstract][Full Text] [Related]
24. Comparative serum proteome analysis of human lymph node negative/positive invasive ductal carcinoma of the breast and benign breast disease controls via label-free semiquantitative shotgun technology.
Hu X; Zhang Y; Zhang A; Li Y; Zhu Z; Shao Z; Zeng R; Xu LX
OMICS; 2009 Aug; 13(4):291-300. PubMed ID: 19624269
[TBL] [Abstract][Full Text] [Related]
25. Proteomics of Cerebrospinal Fluid: Throughput and Robustness Using a Scalable Automated Analysis Pipeline for Biomarker Discovery.
Núñez Galindo A; Kussmann M; Dayon L
Anal Chem; 2015 Nov; 87(21):10755-61. PubMed ID: 26452177
[TBL] [Abstract][Full Text] [Related]
26. Multidimensional protein fractionation of blood proteins coupled to data-independent nanoLC-MS/MS analysis.
Levin Y; Jaros JA; Schwarz E; Bahn S
J Proteomics; 2010 Jan; 73(3):689-95. PubMed ID: 19896566
[TBL] [Abstract][Full Text] [Related]
27. In-Depth Blood Proteome Profiling by Extensive Fractionation and Multiplexed Quantitative Mass Spectrometry.
Zhang X; Sun H; Wang Z; Zhou S; Fu Y; Anthony HA; Peng J
Methods Mol Biol; 2023; 2628():109-125. PubMed ID: 36781782
[TBL] [Abstract][Full Text] [Related]
28. Identification of human serum protein targets of Qianggu Decoction () in primary type I osteoporosis based on tandem mass tag labeling and liquid chromatography-tandem mass spectrometry technology.
Liang BC; Shi XL; Li CW; Shi ZY; He WT; Yao JL; Kong LC; Li XY
Chin J Integr Med; 2017 Oct; 23(10):747-754. PubMed ID: 27389089
[TBL] [Abstract][Full Text] [Related]
29. Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma.
Hoffman SA; Joo WA; Echan LA; Speicher DW
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):43-52. PubMed ID: 17140865
[TBL] [Abstract][Full Text] [Related]
30. Relative protein quantification and accessible biology in lung tumor proteomes from four LC-MS/MS discovery platforms.
Stewart PA; Fang B; Slebos RJ; Zhang G; Borne AL; Fellows K; Teer JK; Chen YA; Welsh E; Eschrich SA; Haura EB; Koomen JM
Proteomics; 2017 Mar; 17(6):. PubMed ID: 28195392
[TBL] [Abstract][Full Text] [Related]
31. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
[TBL] [Abstract][Full Text] [Related]
32. Proteomic profiling of ovarian cancer models using TMT-LC-MS/MS.
Sinclair J; Timms JF
Methods Mol Biol; 2013; 1049():271-84. PubMed ID: 23913223
[TBL] [Abstract][Full Text] [Related]
33. Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.
Wehr AY; Hwang WT; Blair IA; Yu KH
J Proteome Res; 2012 Mar; 11(3):1749-58. PubMed ID: 22264027
[TBL] [Abstract][Full Text] [Related]
34. Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry.
van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(5-6):590-602. PubMed ID: 20116351
[TBL] [Abstract][Full Text] [Related]
35. Comparison of 1-D and 2-D LC MS/MS methods for proteomic analysis of human serum.
Gilar M; Olivova P; Chakraborty AB; Jaworski A; Geromanos SJ; Gebler JC
Electrophoresis; 2009 Apr; 30(7):1157-67. PubMed ID: 19283699
[TBL] [Abstract][Full Text] [Related]
36. Employing TMT quantification in shotgun-MS proteomic analysis: a focus on skeletal muscle.
de Oliveira BM
Methods Mol Biol; 2014; 1156():201-9. PubMed ID: 24791990
[TBL] [Abstract][Full Text] [Related]
37. Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum.
Piersma SR; Fiedler U; Span S; Lingnau A; Pham TV; Hoffmann S; Kubbutat MH; Jiménez CR
J Proteome Res; 2010 Apr; 9(4):1913-22. PubMed ID: 20085282
[TBL] [Abstract][Full Text] [Related]
38. Enhanced Detection of Low-Abundance Human Plasma Proteins by Integrating Polyethylene Glycol Fractionation and Immunoaffinity Depletion.
Liu Z; Fan S; Liu H; Yu J; Qiao R; Zhou M; Yang Y; Zhou J; Xie P
PLoS One; 2016; 11(11):e0166306. PubMed ID: 27832179
[TBL] [Abstract][Full Text] [Related]
39. Human serum proteins fractionated by preparative partition chromatography prior to LC-ESI-MS/MS.
Tucholska M; Bowden P; Jacks K; Zhu P; Furesz S; Dumbrovsky M; Marshall J
J Proteome Res; 2009 Mar; 8(3):1143-55. PubMed ID: 19265436
[TBL] [Abstract][Full Text] [Related]
40. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
Martosella J; Zolotarjova N; Liu H; Nicol G; Boyes BE
J Proteome Res; 2005; 4(5):1522-37. PubMed ID: 16212403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
